Literature DB >> 23571678

Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.

María D Rubio1, Krista Wood, Vahram Haroutunian, James H Meador-Woodruff.   

Abstract

Protein expression abnormalities have been implicated in the pathophysiology of schizophrenia, but the underlying cause of these changes is not known. We sought to investigate ubiquitin and ubiquitin-like (UBL) systems (SUMOylation, NEDD8ylation, and Ufmylation) as putative mechanisms underlying protein expression abnormalities seen in schizophrenia. For this, we performed western blot analysis of total ubiquitination, free ubiquitin, K48- and K63-linked ubiquitination, and E1 activases, E2 conjugases, and E3 ligases involved in ubiquitination and UBL post-translational modifications in postmortem brain tissue samples from persons with schizophrenia (n=13) and comparison subjects (n=13). We studied the superior temporal gyrus (STG) of subjects from the Mount Sinai Medical Center brain collection that were matched for age, tissue pH, and sex. We found an overall reduction of protein ubiquitination, free ubiquitin, K48-linked ubiquitination, and increased K63 polyubiquitination in schizophrenia. Ubiquitin E1 activase UBA (ubiquitin activating enzyme)-6 and E3 ligase Nedd (neural precursor cell-expressed developmentally downregulated)-4 were decreased in this illness, as were E3 ligases involved in Ufmylation (UFL1) and SUMOylation (protein inhibitor of activated STAT 3, PIAS3). NEDD8ylation was also dysregulated in schizophrenia, with decreased levels of the E1 activase UBA3 and the E3 ligase Rnf7. This study of ubiquitin and UBL systems in schizophrenia found abnormalities of ubiquitination, Ufmylation, SUMOylation, and NEDD8ylation in the STG in this disorder. These results suggest a novel approach to the understanding of schizophrenia pathophysiology, where a disruption in homeostatic adaptation of the cell underlies discreet changes seen at the protein level in this illness.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571678      PMCID: PMC3746696          DOI: 10.1038/npp.2013.84

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  54 in total

Review 1.  Superior temporal gyrus in schizophrenia: a volumetric magnetic resonance imaging study.

Authors:  R P Rajarethinam; J R DeQuardo; R Nalepa; R Tandon
Journal:  Schizophr Res       Date:  2000-01-21       Impact factor: 4.939

Review 2.  SUMO--nonclassical ubiquitin.

Authors:  F Melchior
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

3.  Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

Authors:  Frank A Middleton; Karoly Mirnics; Joseph N Pierri; David A Lewis; Pat Levitt
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

4.  NEDD8 recruits E2-ubiquitin to SCF E3 ligase.

Authors:  T Kawakami; T Chiba; T Suzuki; K Iwai; K Yamanaka; N Minato; H Suzuki; N Shimbara; Y Hidaka; F Osaka; M Omata; K Tanaka
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

5.  NEDD8 protein is involved in ubiquitinated inclusion bodies.

Authors:  Afroz Dil Kuazi; Katsumi Kito; Yasuhito Abe; Ryong-Woon Shin; Tetsu Kamitani; Norifumi Ueda
Journal:  J Pathol       Date:  2003-02       Impact factor: 7.996

6.  Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.

Authors:  H Shimura; M G Schlossmacher; N Hattori; M P Frosch; A Trockenbacher; R Schneider; Y Mizuno; K S Kosik; D J Selkoe
Journal:  Science       Date:  2001-06-28       Impact factor: 47.728

7.  Application of cDNA microarrays to examine gene expression differences in schizophrenia.

Authors:  M P Vawter; T Barrett; C Cheadle; B P Sokolov; W H Wood; D M Donovan; M Webster; W J Freed; K G Becker
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

8.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.

Authors:  A Guidotti; J Auta; J M Davis; V Di-Giorgi-Gerevini; Y Dwivedi; D R Grayson; F Impagnatiello; G Pandey; C Pesold; R Sharma; D Uzunov; E Costa; V DiGiorgi Gerevini
Journal:  Arch Gen Psychiatry       Date:  2000-11

9.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Y A Lam; C M Pickart; A Alban; M Landon; C Jamieson; R Ramage; R J Mayer; R Layfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 10.  Sumoylation in neurodegenerative diseases.

Authors:  Petranka Krumova; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

View more
  63 in total

Review 1.  Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Authors:  Carole Gwizdek; Frédéric Cassé; Stéphane Martin
Journal:  Neuromolecular Med       Date:  2013-08-02       Impact factor: 3.843

2.  Gene expression in superior temporal cortex of schizophrenia patients.

Authors:  C Sellmann; L Villarín Pildaín; A Schmitt; F Leonardi-Essmann; P F Durrenberger; R Spanagel; T Arzberger; H Kretzschmar; M Zink; O Gruber; M Herrera-Marschitz; R Reynolds; P Falkai; P J Gebicke-Haerter; F Matthäus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-28       Impact factor: 5.270

Review 3.  What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?

Authors:  Christoph W Turck; Michaela D Filiou
Journal:  Mol Neuropsychiatry       Date:  2015-05-12

4.  Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms.

Authors:  S Mas; P Gassó; E Parellada; M Bernardo; A Lafuente
Journal:  Pharmacogenomics J       Date:  2015-01-27       Impact factor: 3.550

5.  Estrogen Receptor β Agonist Attenuates Endoplasmic Reticulum Stress-Induced Changes in Social Behavior and Brain Connectivity in Mice.

Authors:  Amanda Crider; Tyler Nelson; Talisha Davis; Kiley Fagan; Kumar Vaibhav; Matthew Luo; Sunay Kamalasanan; Alvin V Terry; Anilkumar Pillai
Journal:  Mol Neurobiol       Date:  2018-02-12       Impact factor: 5.590

6.  Synaptic Proteome Alterations in the Primary Auditory Cortex of Individuals With Schizophrenia.

Authors:  Matthew L MacDonald; Megan Garver; Jason Newman; Zhe Sun; Joseph Kannarkat; Ryan Salisbury; Jill Glausier; Ying Ding; David A Lewis; Nathan Yates; Robert A Sweet
Journal:  JAMA Psychiatry       Date:  2020-01-01       Impact factor: 21.596

7.  Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia.

Authors:  Jordyn M Kippe; Toni M Mueller; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2015-06-20       Impact factor: 4.939

8.  Upregulation of GSK3β Contributes to Brain Disorders in Elderly REGγ-knockout Mice.

Authors:  Yiqing Lv; Bo Meng; Hao Dong; Tiantian Jing; Nan Wu; Yingying Yang; Lan Huang; Robb E Moses; Bert W O'Malley; Bing Mei; Xiaotao Li
Journal:  Neuropsychopharmacology       Date:  2015-09-15       Impact factor: 7.853

Review 9.  A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.

Authors:  Valerie J Sydnor; David R Roalf
Journal:  Schizophr Res       Date:  2020-07-25       Impact factor: 4.939

10.  Adolescent social isolation enhances the plasmalemmal density of NMDA NR1 subunits in dendritic spines of principal neurons in the basolateral amygdala of adult mice.

Authors:  J O Gan; E Bowline; F S Lourenco; V M Pickel
Journal:  Neuroscience       Date:  2013-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.